Medical Technology, School of Allied Health Sciences, Walailak University, Tha Sala, Nakhon Si Thammarat, Thailand.
Department of Medical Technology, Institute of Arts and Sciences, Far Eastern University-Manila, Manila, Philippines.
Sci Rep. 2020 Jul 6;10(1):11068. doi: 10.1038/s41598-020-68082-3.
Mixed Plasmodium malaria infections can lead to severe malaria. This systematic review and meta-analysis aimed to explore the prevalence of severe mixed Plasmodium malaria infection and to compare it with the prevalence of severe P. falciparum malaria mono-infection across the included studies. Original English-language research articles from PubMed, Scopus, and ISI Web of Science were identified and screened. Articles reporting the number of mixed infections and the number of severe mixed infections were used to determine the main outcome of this study, while the number of P. falciparum infections and the number of severe P. falciparum infections were used to determine the secondary outcome of this study. For the main outcome, the pooled prevalence and 95% confidence interval (CI) of severe mixed infections was analysed using STATA software version 15.0 (Stata Corp, College Station, TX, USA). For the secondary outcome, the rate of severe mixed infections compared to severe P. falciparum infections was analysed using the meta-analysis approach, and summary odds ratios (ORs) and 95% CIs were calculated. Random-effects models were used to produce the summary ORs. The Mantel-Haenszel method and calculated I were also reported to test whether there was heterogeneity among the included studies. Publication bias was also assessed using funnel plots. The meta-analysis of secondary outcomes was conducted using Review Manager 5.3 software (Cochrane Community). A total of 894,561 malaria patients were reported in all 16 included studies. Overall, a pooled analysis showed that 9% (2,006/35,768, 95% CI 7.0-12.0%) of patients with mixed Plasmodium infection had severe mixed infection. A meta-analysis of 14 studies demonstrated that patients with mixed Plasmodium infection (1,999/35,755) and patients with P. falciparum malaria (9,249/294,397) had an equal risk of developing severe malaria (OR 0.93, 95% CI 0.59-1.44). Both mixed infection and P. falciparum mono-infection showed a similar trend of complications in which severe anaemia, pulmonary failure, and renal impairment were the three most common complications found. However, patients with mixed infection had a higher proportion of severe anaemia and pulmonary complications than those with P. falciparum infection. Moreover, patients with mixed infection had a higher proportion of multiple organ failure than those with P. falciparum mono-infection. Mixed Plasmodium spp. infections were common but often unrecognized or underestimated, leading to severe complications among these malaria patients. Therefore, in routine clinical laboratories, using an accurate combination of diagnostic procedures to identify suspected patients with mixed infections is crucial for therapeutic decisions, prompt treatment, and effective patient management.
混合疟原虫感染可导致严重疟疾。本系统评价和荟萃分析旨在探讨严重混合疟原虫感染的流行率,并将其与纳入研究中严重恶性疟原虫单感染的流行率进行比较。从 PubMed、Scopus 和 ISI Web of Science 中确定并筛选了原始英文研究文章。使用报告混合感染数量和严重混合感染数量的文章来确定本研究的主要结局,而使用恶性疟原虫感染数量和严重恶性疟原虫感染数量来确定本研究的次要结局。对于主要结局,使用 STATA 软件版本 15.0(StataCorp,College Station,TX,USA)分析严重混合感染的汇总患病率和 95%置信区间(CI)。对于次要结局,使用荟萃分析方法分析严重混合感染与严重恶性疟原虫感染的比率,并计算汇总优势比(OR)和 95%CI。使用随机效应模型生成汇总 OR。还报告了 Mantel-Haenszel 方法和计算的 I,以检验纳入研究之间是否存在异质性。还使用漏斗图评估发表偏倚。使用 Review Manager 5.3 软件(Cochrane 社区)对次要结局的荟萃分析进行了分析。所有 16 项纳入研究共报告了 894,561 例疟疾病例。总体而言,汇总分析显示,2%(2,006/35,768,95%CI 7.0-12.0%)的混合疟原虫感染患者有严重混合感染。对 14 项研究的荟萃分析表明,混合疟原虫感染患者(1,999/35,755)和恶性疟原虫疟疾患者(9,249/294,397)发生严重疟疾的风险相同(OR 0.93,95%CI 0.59-1.44)。混合感染和恶性疟原虫单感染均表现出类似的并发症趋势,其中严重贫血、呼吸衰竭和肾功能损害是最常见的三种并发症。然而,混合感染患者的严重贫血和肺部并发症比例高于恶性疟原虫感染患者。此外,混合感染患者的多器官衰竭比例高于恶性疟原虫单感染患者。混合疟原虫感染很常见,但往往未被识别或低估,导致这些疟疾病例出现严重并发症。因此,在常规临床实验室中,使用准确的诊断程序组合来识别疑似混合感染患者对于治疗决策、及时治疗和有效患者管理至关重要。